Physicians' attitudes toward generic substitutions of antiseizure drugs in epilepsy.
Patrik OlssonJulia FreijMaria Compagno StrandbergCecilia AdelöwHampus ÖstlundMartin LindbergerKristina KällénPublished in: Acta neurologica Scandinavica (2021)
Neurologists generally accept the use of generic antiseizure compounds. Patient preference to remain on brand-name drug treatment was the most important factor that led to avoiding a switch. Our results may constitute material for consensus discussions to decide on quality indicators of interest for future research on substitution outcomes.